Optimization of aminolevulinic acid delivery by iontophoresis

Journal of Controlled Release

Volumn 88, Issue 1, 2003, Pages 65-70

  Lopez, Renata F V ^a,b,c   Bentley, M Vitória L B ^c   Delgado Charro, M Begoña ^a,b   Guy, Richard H ^a,b  

^a Ctr Interuniv Rech d'Enseignement   (France)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aminolevulinic acid; Iontophoresis; Photodynamic therapy; Skin cancer

Indexed keywords

AMINOLEVULINIC ACID; AMPHOLYTE; DIMETHYL SULFOXIDE; ELECTROLYTE; SODIUM CHLORIDE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ELECTRODE; IONIC STRENGTH; IONTOPHORESIS; PRIORITY JOURNAL;

EID: 0037436012     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00456-X     Document Type: Article

References (25)

1. De Rosa F.S., Marchetti J.M., Thomazini J.A., Tedesco A.C., Bentley M.V.L.B. A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J. Controlled Release. 65:2000;359-366.
2. Lui H., Salasche S., Kollias N., Flotte T., Mclean D., Anderson R.R. Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid; a clinical and histological study. Arch. Dermatol. 131:1995;737-738.
3. Kennedy J.C., Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B. 14:1992;275-292.
4. Svanberg K., Anderson T., Killander D., Wang I., Stenram U., Andersson-Engels S., Berg R., Johansson J., Svanberg S. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-amino levulinic acid sensitization and laser irradiation. Br. J. Dermatol. 130:1994;743-751.
5. Fritsch C., Lehmann P., Stahl W., Schulte K.W., Blohm E., Lang K., Sies H., Ruzicka T. Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of γ-aminolaevulinic acid. Br. J. Cancer. 79:1999;1603-1608.
6. Cairnduff F., Stringer M., Hudson E., Ashand D., Brown S. Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br. J. Cancer. 69:1994;605-608.
7. Lopez R.F.V., Bentley M.V.L.B., Delgado-Charro M.B., Guy R.H. Iontophoretic delivery of 5-aminolevulinic acid (ALA): Effect of pH. Pharm. Res. 18:2001;311-315.
8. Green P.G., Hinz R.S., Kim A., Szoka F.C. Jr., Guy R.H. Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharm. Res. 8:1991;1121-1127.
9. Siddiqui O., Roberts M.S., Polack A.E. The effect of iontophoresis and vehicle pH on the in-vitro permeation of lignocaine through human stratum corneum. J. Pharm. Pharmacol. 37:1985;732-735.
10. Burnette R.R., Marrero D. Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin. J. Pharm. Sci. 75:1986;738-743.
11. Glikfeld P., Cullander C., Hinz R.S., Guy R.H. A new system for in vitro studies of iontophoresis. Pharm. Res. 5:1988;443-446.
12. Green P.G., Hinz R.S., Cullander C., Yamane G., Guy R.H. Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro. Pharm. Res. 8:1991;1113-1120.
13. Pikal M.J. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Del. Rev. 9:1992;201-237.
14. Van der Geest R., Hueber F., Szoka F.C., Guy R.H. Iontophoresis of bases, nucleosides, and nucleotides. Pharm. Res. 13:1996;553-558.
15. Kim A., Green P.G., Rao G., Guy R.H. Convective solvent flow across the skin during iontophoresis. Pharm. Res. 10:1993;1315-1320.
16. Novo M., Hüttmann G., Diddens H. Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumors. J. Photochem. Photobiol. B: Biol. 34:1996;143-148.
17. Pikal M.J., Shah S. Transport mechanism in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes. Pharm. Res. 7:1990;222-229.
18. Santi P., Guy R.H. Reverse iontophoresis - Parameters determining electroosmotic flow: I. pH and ionic strength. J. Controlled Release. 38:1996;159-165.
19. Merino V., López A., Hochstrasser D., Guy R.H. Noninvasive sampling of phenylalanine by reverse iontophoresis. J. Controlled Release. 61:1999;65-69.
20. Malik Z., Kostenich G., Roitman L., Ehrenberg B., Orenstein A. Topical application of 5-aminolevulinic acid, DMSO, and EDTA: protoporphyrin IX accumulation in skin and tumors of mice. J. Photochem. Photobiol. B: Biol. 28:1995;213-218.
21. Peng Q., Warloe T., Moan J., Heyerdahl H., Steen H.B., Nesland J.M., Giercksky K.E. Distribution of 5-aminolevulinic acid-induced porphyrins in nodoulcerative basal cell carcinoma. Photochem. Photobiol. 62:1995;906-913.
22. Martin A., Tope W.D., Grevelink J.M., Starr J.C., Fewkes J.L., Flotte T.J., Deutsch T.F., Anderson R.R. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch. Dermatol. Res. 287:1995;665-674.
23. Calzavara-Pinton P.G. Repetitive photodynamic therapy with topical delta-aminolevulinic acid as an appropriate approach to the routine treatment of superficial nonmelanoma skin tumors. J. Photochem. Photobiol. B. 29:1995;53-57.
24. Kalka K., Merk H., Mukhtar H. Photodynamic therapy in dermatology. J. Am. Acad. Dermatol. 42:2000;389-413.
25. Gerscher S., Connelly J.P., Griffiths J., Brown S.B., MacRobert A.J., Wong G., Rhodes L.E. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo. Photochem. Photobiol. 75:2000;569-574.